Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Sublingual Nitroglycerin: A Multi-center, Single-blind, Randomized Controlled Trial

NCT03756116 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.

NCT NCT03756116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03756116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Sublingual Nitroglycerin: A Multi-center, Single-blind, Randomized Controlled Trial
Lead sponsor
The Second Hospital of Nanjing Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2018
Completion date
October 1, 2020
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epinephrine, post-ercp acute pancreatitis